| Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice P Seale, HM Conroe, J Estall, S Kajimura, A Frontini, J Ishibashi, P Cohen, ... The Journal of clinical investigation 121 (1), 96-105, 2011 | 1295 | 2011 |
| Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5 JH Choi, AS Banks, JL Estall, S Kajimura, P Boström, D Laznik, JL Ruas, ... Nature 466 (7305), 451-456, 2010 | 917 | 2010 |
| A PGC-1α isoform induced by resistance training regulates skeletal muscle hypertrophy JL Ruas, JP White, RR Rao, S Kleiner, KT Brannan, BC Harrison, ... Cell 151 (6), 1319-1331, 2012 | 656 | 2012 |
| Transcriptional control of adipose lipid handling by IRF4 J Eguchi, X Wang, S Yu, EE Kershaw, PC Chiu, J Dushay, JL Estall, ... Cell metabolism 13 (3), 249-259, 2011 | 527 | 2011 |
| GLP-1 receptor activation improves β cell function and survival following induction of endoplasmic reticulum stress B Yusta, LL Baggio, JL Estall, JA Koehler, DP Holland, H Li, D Pipeleers, ... Cell metabolism 4 (5), 391-406, 2006 | 523 | 2006 |
| β-Aminoisobutyric acid induces browning of white fat and hepatic β-oxidation and is inversely correlated with cardiometabolic risk factors LD Roberts, P Boström, JF O’Sullivan, RT Schinzel, GD Lewis, A Dejam, ... Cell metabolism 19 (1), 96-108, 2014 | 501 | 2014 |
| The unfolded protein response mediates adaptation to exercise in skeletal muscle through a PGC-1α/ATF6α complex J Wu, JL Ruas, JL Estall, KA Rasbach, JH Choi, L Ye, P Boström, HM Tyra, ... Cell metabolism 13 (2), 160-169, 2011 | 314 | 2011 |
| Development of insulin resistance in mice lacking PGC-1α in adipose tissues S Kleiner, RJ Mepani, D Laznik, L Ye, MJ Jurczak, FR Jornayvaz, JL Estall, ... Proceedings of the national academy of sciences 109 (24), 9635-9640, 2012 | 310 | 2012 |
| Integrated Regulation of Hepatic Metabolism by Fibroblast Growth Factor 21 (FGF21) in Vivo FM Fisher, JL Estall, AC Adams, PJ Antonellis, HA Bina, JS Flier, ... Endocrinology 152 (8), 2996-3004, 2011 | 248 | 2011 |
| PGC-1α regulates a HIF2α-dependent switch in skeletal muscle fiber types KA Rasbach, RK Gupta, JL Ruas, J Wu, E Naseri, JL Estall, ... Proceedings of the National Academy of Sciences 107 (50), 21866-21871, 2010 | 162 | 2010 |
| Glucagon-like peptide-2 JL Estall, DJ Drucker Annu. Rev. Nutr. 26, 391-411, 2006 | 159 | 2006 |
| Sensitivity of lipid metabolism and insulin signaling to genetic alterations in hepatic peroxisome proliferator–activated receptor-γ coactivator-1α expression JL Estall, M Kahn, MP Cooper, FM Fisher, MK Wu, D Laznik, L Qu, ... Diabetes 58 (7), 1499-1508, 2009 | 157 | 2009 |
| PGC-1α negatively regulates hepatic FGF21 expression by modulating the heme/Rev-Erbα axis JL Estall, JL Ruas, CS Choi, D Laznik, M Badman, E Maratos-Flier, ... Proceedings of the National Academy of Sciences 106 (52), 22510-22515, 2009 | 154 | 2009 |
| Mucosal adaptation to enteral nutrients is dependent on the physiologic actions of glucagon-like peptide-2 in mice ED Shin, JL Estall, A Izzo, DJ Drucker, PL Brubaker Gastroenterology 128 (5), 1340-1353, 2005 | 153 | 2005 |
| Glucagon-like peptide (GLP)-2 action in the murine central nervous system is enhanced by elimination of GLP-1 receptor signaling J Lovshin, J Estall, B Yusta, TJ Brown, DJ Drucker Journal of Biological Chemistry 276 (24), 21489-21499, 2001 | 147 | 2001 |
| Estrogen signals through peroxisome proliferator-activated Receptor− γ coactivator 1α to reduce oxidative damage associated with diet-induced fatty liver disease A Besse-Patin, M Léveillé, D Oropeza, BN Nguyen, A Prat, JL Estall Gastroenterology 152 (1), 243-256, 2017 | 118 | 2017 |
| Separation of the gluconeogenic and mitochondrial functions of PGC-1α through S6 kinase Y Lustig, JL Ruas, JL Estall, JC Lo, S Devarakonda, D Laznik, JH Choi, ... Genes & development 25 (12), 1232-1244, 2011 | 113 | 2011 |
| ErbB signaling is required for the proliferative actions of GLP-2 in the murine gut B Yusta, D Holland, JA Koehler, M Maziarz, JL Estall, R Higgins, ... Gastroenterology 137 (3), 986-996, 2009 | 113 | 2009 |
| Glucagon-like peptide-2 receptor activation engages bad and glycogen synthase kinase-3 in a protein kinase A-dependent manner and prevents apoptosis following inhibition of … B Yusta, J Estall, DJ Drucker Journal of Biological Chemistry 277 (28), 24896-24906, 2002 | 110 | 2002 |
| Glucagon and glucagon-like peptide receptors as drug targets JL Estall, DJ Drucker Current pharmaceutical design 12 (14), 1731-1750, 2006 | 103 | 2006 |
Daniel J. DruckerLunenfeld-Tanenbaum Research Institute, Mt. Sinai Hospital, University of TorontoПотвърден имейл адрес: lunenfeld.ca
